Build your startup in Cyprus. Keep more of what you earn.

Cyprus offers a 20% tax deduction for qualifying innovative companies, reducing the effective corporate tax rate from 15% to 12% on qualifying profits. The deduction is available to companies engaged in research and development activities that result in innovation — new products, processes, or services that represent a technological advance. The company must maintain records of its R&D activities and expenditure to substantiate the claim.

The innovative company deduction is not the same as the R&D super-deduction. The innovative company deduction reduces the corporate tax base by 20% for qualifying companies — a structural rate reduction. The R&D super-deduction increases the deductible amount of R&D spend by 20% (120% instead of 100%). Both can apply simultaneously: a qualifying innovative company deducts 120% of its R&D spend, and then the resulting taxable profit is reduced by a further 20% through the innovative company deduction. The combined effect can reduce the effective corporate tax rate to single digits.

For a startup generating €500,000 in qualifying IP income, the stack works as follows: the IP Box regime exempts 80% of the IP profits, leaving €100,000 taxable. The innovative company deduction reduces this by 20% to €80,000. Corporate tax at 15% on €80,000 is €12,000 — an effective rate of 2.4% on the original €500,000. Combined with the R&D super-deduction on the expenditure side, the overall tax burden on a startup's innovation-driven profits can be remarkably low. For the full R&D expenditure rules and qualifying categories, see our R&D tax incentives guide.

The Cyprus IP Box regime taxes qualifying intellectual property income at an effective rate of approximately 3%. The mechanism: 80% of qualifying IP profits are exempt from tax, and the remaining 20% is taxed at the corporate rate. With the 2026 corporate rate of 15%, the effective rate on IP income is 20% times 15% = 3%. This is one of the lowest effective IP tax rates in the EU.

The regime uses the modified nexus approach, which requires a connection between the IP income and the R&D activity that created it. Only IP developed by the company itself (or by outsourced contractors under certain conditions) qualifies. Acquired IP does not qualify. The nexus fraction determines what portion of IP income is qualifying — it is based on the ratio of qualifying R&D expenditure to total R&D expenditure. If all R&D was done in-house, the nexus fraction is 100% and all IP income qualifies for the 80% exemption.

Qualifying IP includes patents, software, and other copyrighted works. Trademarks and brand-related IP do not qualify. The income covered includes royalties from licensing, embedded IP income (where IP is bundled into a product or service), and capital gains from the sale of qualifying IP. The IP Box regime is available immediately — there is no pre-approval process, but the company must self-assess and maintain documentation of its R&D activities and nexus calculation. The IP Box guide covers the full regime in detail.

The R&D super-deduction allows companies to deduct 120% of qualifying research and development expenditure from their taxable profits. For every €100 spent on R&D, €120 is deductible — a 20% uplift on the actual spend. The super-deduction was extended to 2030, providing long-term certainty for startups planning multi-year R&D programmes. Qualifying expenditure includes salaries of R&D personnel, materials consumed in R&D, subcontracted R&D work (with conditions), and overheads directly attributable to R&D activities.

The super-deduction is separate from the IP Box regime, and the two stack. A startup spends €200,000 on R&D to develop a software product. The super-deduction allows €240,000 to be deducted from taxable profits (120% of €200,000). If the product generates €500,000 in IP income, the IP Box regime exempts 80% of that income, leaving €100,000 taxable. The €240,000 R&D deduction reduces the €100,000 taxable IP income to zero — and creates a €140,000 loss that can be carried forward. The combined effect: zero tax on €500,000 of IP revenue in the development year.

Qualifying R&D activities must meet the definition of research and experimental development under the OECD Frascati Manual — systematic creative work to increase the stock of knowledge and devise new applications. Routine software development may not qualify; the activity must involve resolving technical uncertainty. The company should document its R&D activities, the technical uncertainties addressed, and the expenditure incurred. For the full qualifying expenditure categories and documentation requirements, see the R&D tax incentives page — do not duplicate the detail here.

New for 2026: employees who receive shares or stock options under an approved share-based payment scheme are taxed at a flat 8% rate on the value of the shares received, instead of the progressive 0–35% income tax rate. This is the single most important change for startups in the 2026 reform, because equity compensation is how most early-stage companies attract and retain talent — and the difference between 8% and 35% on a significant equity grant can be tens of thousands of euros.

Under the old rules, share-based compensation was taxed as employment income at the progressive scale. An employee receiving €50,000 worth of shares would pay up to €17,500 in tax (35% top rate). Under the new 8% flat rate, the tax on the same grant is €4,000 — a saving of €13,500. For a senior engineer receiving €100,000 in equity, the saving is €27,000. This makes Cyprus dramatically more competitive for startups competing against UK, German, and US companies for talent.

The scheme applies to approved share-based payment plans — meaning the plan must meet certain conditions and be registered with the Tax Department. The shares or options must be granted as part of a formal employee equity scheme, not as ad hoc bonuses. The 8% rate applies at the point of vesting or exercise (when the employee receives the actual shares), not at the point of grant. If the employee later sells the shares, any gain is taxed as a capital gain — but for Cyprus tax residents, the sale of shares in a Cyprus company is generally exempt from capital gains tax.

This incentive is barely covered elsewhere in the tax advisory market. Most guides to Cyprus startup incentives mention the IP Box and R&D deduction but miss the 8% share-based payment rate entirely. For startups that compensate employees with equity, this is the incentive that matters most on a per-employee basis. Combined with the IP Box (3% on IP income), the R&D super-deduction (120% on R&D spend), and the innovative company deduction (20% reduction), Cyprus now offers one of the most competitive startup tax regimes in Europe.